Chargement en cours...

The Role of Age on Dose Limiting Toxicities (DLTs) in Phase I Dose-escalation Trials

PURPOSE: Elderly oncology patients are not enrolled in early phase trials in proportion to the numbers of geriatric patients with cancer. There may be concern that elderly patients will not tolerate investigational agents as well as younger patients resulting in a disproportionate number of dose-lim...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Cancer Res
Auteurs principaux: Schwandt, A, Harris, P. J., Hunsberger, S., Deleporte, A., Smith, G. L., Vulih, D., Anderson, B. D., Ivy, S. P.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5207798/
https://ncbi.nlm.nih.gov/pubmed/25028396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-0866
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!